Latest News
Featured News
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell Attends and Sponsors the Annual Melanoma Patient Meeting
Scancell to present at the Next-Gen Immuno-Oncology Conference
Scancell Change of Auditor
Directorate Change and Appointment of Head of Development
Interim Results for the six months ended 31 October 2023
Notice of Interim Results and Presentation
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.